244 related articles for article (PubMed ID: 6153847)
1. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study.
Milman N; Scheibel J; Jessen O
Acta Derm Venereol; 1980; 60(1):85-7. PubMed ID: 6153847
[TBL] [Abstract][Full Text] [Related]
2. [Lysine therapy of recurrent herpes simplex labialis].
Milman N; Jessen O; Scheibel J
Ugeskr Laeger; 1979 Oct; 141(43):2960-2. PubMed ID: 392853
[No Abstract] [Full Text] [Related]
3. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis.
DiGiovanna JJ; Blank H
Arch Dermatol; 1984 Jan; 120(1):48-51. PubMed ID: 6419679
[TBL] [Abstract][Full Text] [Related]
4. [Lysine prevention in recurrent labial herpes simplex].
Milman N; Scheibel J; Jessen O
Ugeskr Laeger; 1980 May; 142(19):1202-3. PubMed ID: 6773197
[No Abstract] [Full Text] [Related]
5. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis.
Griffith RS; Walsh DE; Myrmel KH; Thompson RW; Behforooz A
Dermatologica; 1987; 175(4):183-90. PubMed ID: 3115841
[TBL] [Abstract][Full Text] [Related]
6. Failure of lysine in frequently recurrent herpes simplex infection.
Simon CA; Van Melle GD; Ramelet AA
Arch Dermatol; 1985 Feb; 121(2):167-8. PubMed ID: 3919651
[No Abstract] [Full Text] [Related]
7. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
Busch R; Graubaum HJ; Gruenwald J; Faergemann J
Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
Lawee D; Rosenthal D; Aoki FY; Portnoy J
CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of recurrent herpes labialis using a herpes simplex Type-I subunit vaccine. A prospective randomized double-blind multicenter study].
Altmeyer P; Wehrenberg O; Holzmann H; Paul E; Kimmig WK; Wassilew SW; Petres J; Korger G
Hautarzt; 1991 Dec; 42(12):759-63. PubMed ID: 1662671
[TBL] [Abstract][Full Text] [Related]
10. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
12. Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections.
Myers MG; Oxman MN; Clark JE; Arndt KA
N Engl J Med; 1975 Nov; 293(19):945-9. PubMed ID: 170521
[TBL] [Abstract][Full Text] [Related]
13. Herpes labialis treatment with acyclovir 5 per cent ointment.
Raborn GW; McGaw WT; Grace M; Houle L
J Can Dent Assoc; 1989 Feb; 55(2):135-7. PubMed ID: 2645030
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient hosts.
Aiuti F; Sirianni MC; Paganelli R; Stella A; Turbessi G; Fiorilli M
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):81-6. PubMed ID: 6341261
[TBL] [Abstract][Full Text] [Related]
15. LongoVital and herpes labialis: a randomised, double-blind, placebo-controlled study.
Pedersen A
Oral Dis; 2001 Jul; 7(4):221-5. PubMed ID: 11575872
[TBL] [Abstract][Full Text] [Related]
16. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
Koytchev R; Alken RG; Dundarov S
Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
[TBL] [Abstract][Full Text] [Related]
17. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
[TBL] [Abstract][Full Text] [Related]
18. Iontophoretic application of idoxuridine for recurrent herpes labialis: report of preliminary clinical trials.
Gangarosa LP; Merchant HW; Park NH; Hill JM
Methods Find Exp Clin Pharmacol; 1979 Jun; 1(2):105-9. PubMed ID: 552584
[TBL] [Abstract][Full Text] [Related]
19. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.
Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC
N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride.
McCune MA; Perry HO; Muller SA; O'Fallon WM
Cutis; 1984 Oct; 34(4):366-73. PubMed ID: 6435961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
